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____________________________________________________________________________________ 
Mediator, a large protein complex exclusive to eukaryotes, is a master regulator of cell-type 
specific gene expression. Mediator functions as an adapter that connects activators bound at 
enhancers to the transcription pre-initiation complex (PIC) located at the promoter. Our 
research focuses on how Mediator influences the differentiation of adipose-derived 
mesenchymal stem cells (ASCs). ASCs are harvested from adult donors and have the ability to 
self-renew and can differentiate down chondrogenic, osteogenic, and adipogenic lineages. We 
recently published findings indicating that knockdown of the Mediator subunit MED31 reduces 
adipogenesis in bone marrow-derived MSCs. We are now focused on MED12, a subunit of the 
Mediator complex kinase domain that appears to have a significant role in maintaining cell 
state. Our goal is to understand MED12’s dual role as both a Mediator subunit in the regulatory 
kinase module and as a coactivator of transcription. We hypothesize that the loss of MED12 
disrupts adipogenic differentiation in ASCs. Previously published research indicates MED12 
coactivates β-catenin, a driver of adipogenesis, but little research currently links MED12 to the 
regulation of adipogenesis. We have performed siRNA-mediated knockdowns of MED12 in 
ASCs prior to inducing adipogenesis. ASCs display reduced adipogenesis as demonstrated by 
images of cell morphology and lipid vesicle staining. We have also optimized our sonication 
protocol for chromatin immunoprecipitation (ChIP) experiments and we are currently 
investigating MED12 genomic occupancy in order to determine the direct gene targets of 
MED12 during adipogenesis. Overall, this research is important for elucidating the 
requirements for proper regulation of differentiation of clinically-relevant ASCs, and the 
broader understanding of Mediator’s function in ASCs will help foster their use in clinical 
applications such as regenerative medicine. 
 
 
 
 
 
 
 
 
 
 
 
 
